ENTRADA THERAPEUTICS, INC. (TRDA) Free cash flow 2020–2025
ENTRADA THERAPEUTICS, INC. (TRDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$129.6MFY2025 · since FY2020: -$27.9M → -$129.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.6M | -189.7% |
| FY2024 | -$44.7M | -133.3% |
| FY2023 | $134.2M | +238.8% |
| FY2022 | -$96.7M | -74.4% |
| FY2021 | -$55.4M | -98.8% |
| FY2020 | -$27.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRDA financial trends
TRDA RevenueTRDA Net incomeTRDA Net marginTRDA Gross profitTRDA Gross marginTRDA Operating incomeTRDA Operating marginTRDA Operating cash flowTRDA Capital expendituresTRDA Return on equityTRDA Stock buybacksTRDA Dividends paidTRDA Total assetsTRDA Total liabilitiesTRDA Shareholders’ equityTRDA overview →